update from section chief
hematology
Stephanie Halene, MD, PhD
T
he Section of Hematology members provide evidence-based compassionate care
to patients and families; conduct basic, translational, population, and clinical research; design programs to promote public health; and train the next generation of experts in hematological malignancies and classical hematology patient care and research. Under the leadership of Section Chief Stephanie Halene, MD, PhD, the section has grown to 25 physicians, 29 advanced practice providers, 23 clinical staff, seven researchers, and eight support staff. Halene was officially named section chief in December 2020 after serving as interim chief for 16 months.
52
annual report 2021
Patient Care / Clinical Services Along with staffing the Duffy Firm, Stem Cell Transplant and Cell Therapy Service, and Hematology Consult Services at both campuses of Yale New Haven Hospital, the “Red Team” Hematology Hospitalist Service was added in the summer of 2021 to expand the team’s service for inpatient care. The section also staffs outpatient centers for myeloid malignancies, lymphoma, and sickle cell therapies in Smilow
Cancer Hospital; myeloma and classical hematology at North Haven Medical Center, where program management is supervised by Terri Parker, MD; and through the Smilow Care Centers throughout Connecticut and Rhode Island. Efforts to harmonize care where possible and expand research are under way. Robert Bona, MD, joined the section in July 2020 and became the director of the Classical Hematology Program, which has expanded under his leadership. In July 2021, Cece Calhoun, MD, MSPH, MBA,